Liver International · 2022 · 10 citations · 20 references
Life SciencesImmunologyTransplant ImmunologyTransplant PharmacotherapyTransplant SurgeryAllograft RejectionAntibody-mediated RejectionCalcineurin InhibitorsDonor-specific AntibodiesLiver TransplantationMaintenance ImmunosuppressionAllograft Biopsy DiagnosisCalcineurin Inhibitor ImmunosuppressionDonor-specific Antibody ScreeningDonor-specific Hla AntibodiesLiver Allograft BiopsyLiver Transplant PathologyLiver Transplant RejectionMycophenolic Acid Therapy
BACKGROUND & AIMS: Low calcineurin inhibitor (CNI) levels expose liver transplant recipients to rejection episodes and potentially to antibody-mediated rejection. There are little data on the impact of CNI-free immunosuppression on de novo donor-specific HLA antibody (dnDSA) development. Here we evaluated the prevalence of dnDSA in liver transplant recipients on CNI-free maintenance regimens and their associations with histopathological abnormalities of allografts. METHODS: Seven hundred and twenty-seven liver transplant recipients underwent a first liver transplant between 2000 and 2018 in three French transplant centres and had protocolized follow-up with dnDSA screening and allograft biopsy 1, 5 and 10 years after transplantation. RESULTS: CNIs were withdrawn in 166 (22.8%) patients with or without conversion to mammalian target of rapamycin inhibitors and/or maintenance with mycophenolic acid. DSA were present after withdrawal in 30.1% (50/166) patients on CNI-free immunosuppression compared with 16% (90/561) on CNI maintenance therapy (p < 0.001). The cumulative incidence of dnDSA 10 years after transplant was 20% in the CNI group versus 28% in the CNI-free group (p < 0.01). dnDSAs were associated with histological graft abnormalities (significant allograft fibrosis or rejection) (HR 2.24, 95% CI 1.2-4.1; p = 0.01). In univariate Cox regression analysis, being on a CNI-free regimen did not impact graft histology. CONCLUSIONS: Patients on a CNI-free IS regimen have a higher prevalence of dnDSA than patients on a standard IS regimen. dnDSAs but not CNI-free immunosuppression were associated with abnormal allograft histology.
20
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Pierre Bédossa, Thierry Poynard · Hepatology · 1996 · 4K citations · Full text
Anthony J. Demetris, Christopher Bellamy, Stefan G. Hübscher et al. · American Journal of Transplantation · 2016 · 627 citations · Full text
Medicine, Immunology, Pathology +17